
A physician-reviewed guide to TRT candidacy: the two findings required for a diagnosis, why 300 ng/dL is not an automatic threshold, what delays or rules out treatment, and the conditions commonly mistaken for low testosterone.

Can women use tesamorelin? A physician-reviewed look at what the FDA label and clinical trials actually say about abdominal fat, dosing, pregnancy, side effects and monitoring.

From a friendship formed through Brazilian jiu-jitsu to a physician-led practice in Jupiter, NovaGenix celebrates ten years of care, community and patient relationships.

Compare two approaches to low testosterone, with a focus on fertility goals, symptom evidence, side effects, testing, and the complete cost of care.

A physician-led guide to NCAA banned peptides, steroids, medical exceptions, supplement risk, and what athletes should verify before taking anything.

Perimenopause is a years-long transition; menopause is confirmed after 12 months without a period. Learn how symptoms, diagnosis, and treatment differ.

An FDA advisory committee recommended six peptide substances for possible 503A-list inclusion in July 2026. Here is what that nonbinding vote means—and what it does not mean—for patients.

Retatrutide is an investigational triple agonist—not an FDA-approved medication. Learn what Phase 2 and Phase 3 research shows, known risks, and what patients can legally access today.

A physician-led decision guide to 14 questions men should ask before TRT, including diagnosis, safety, fertility, cost, hidden fees, monitoring and provider selection.
Learn what you want to know about hormone therapy by scheduling a free consultation.
Contact Us Today609 N Hepburn Ave Ste 106, Jupiter, FL 33458
Monday - Friday: 9:00 am - 5:00 pm | Saturday-Sunday: Closed